The final version of the JA1 WP5 pilot assessment report is now published
2 January 2013
We are pleased to present the final version of the WP5 JA1 pilot assessment using the draft model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and guidelines.
Objective of the pilot rapid assessment
The purpose of the pilot was to test the usability of the draft HTA Core Model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and draft guidelines that were developed in work package 5 of Joint Action 1. In addition, the pilot aimed at gathering experience of producing an assessment in an international setting (a co-production of various European Health Technology Assessment agencies).
The report presents the results of the actual rapid assessment. However, it also provides information on the objectives of the pilot, organisational aspects of the pilot and a discussion about the pilot assessment process (authors’ and readers’ perceptions) as well as recommendations for future rapid relative effectiveness assessment projects.
Based on the experience in this pilot the draft HTA Core Model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and draft guidelines were improved.